Averion International Corp.

Averion and Brazil-Based CRO BIOCANCER Sign Strategic Alliance Agreement

Published in Cancer Weekly, September 11th, 2007

Averion International Corp. (OTCBB:AVRO) and Brazil-based BIOCANCER announced the signing of a non-exclusive agreement to jointly market and contract complementary services to biotechnology, pharmaceutical and medical device companies. BIOCANCER is a full-service site management and clinical research organization (CRO) with a focus on oncology.

"This agreement expands our reach to South America, providing us with access to leading clinical sites and large patient populations," said Philip Lavin, PhD, Averion International Chief Executive Officer. "In line with our strategy to achieve rapid market growth, we plan to continue building on our international oncology CRO...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cancer Weekly

Source: Cancer Weekly (2007-09-11)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry